Circulating Tumor Cells (CTCs) A prognostic biomarker in Patients with Hepatocellular Carcinoma
Phase 3
Completed
- Conditions
- Hepatocellular carcinomaCirculating tumor cells, liquid biopsy, hepatocellular carcinoma, biomarker
- Registration Number
- TCTR20211226001
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
The inclusion criteria were newly diagnosed HCC patients with age more than 18 years. The diagnosis of HCC was defined according to American Association of the Study of Liver Diseases guidelines.
Exclusion Criteria
The exclusion criteria were patients with previous or concurrent other malignancies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival 3 years Kaplan-Meier method
- Secondary Outcome Measures
Name Time Method Factors association with survival 3 years Cox proportional hazard analysis